Tokyo
Japan
Tokyo Shinagawa Hospital
mRNA vaccine, lipid nanoparticle, ionisable lipid, vaccine reactogenicity, interleukin-1
Nontuberculous mycobacteria, MPO-ANCA, microscopic polyangiitis, rituximab, erythromycin, neutrophil extracellular traps